CNCure biotech
Hwasun, Cholla-namdo, South Korea
About CNCure biotech
CNCure specializes in the development of radiopharmaceuticals and bacterial-based cancer therapies. The company's offerings include an innovative microbial platform for cancer therapy, molecular imaging spies for making informed decisions, and a radio-theranostics platform for simultaneous disease diagnosis and treatment, providing healthcare professionals with science and technology to diagnose diseases early and treat them effectively to improve health conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Jan 2021)
- Website: cncure.co.kr
- Phone: +82-61-373-9005
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/cncure-biotech-2516760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.